Search
Search
About
Log in
Join
Experiences with
Venclyxto
Posts
Communities
106 public posts
Filter results
CLL Speaking Opportunity!
Are you a CLL patient with a p17 deletion on Venclexta and are able to travel? If so, we may have a speaking opportunity for you. If you meet the above criteria and want to know more information, please email autumn@patientpower.info
Are you a CLL patient with a p17 deletion on Venclexta and are able to travel? If so, we may have a speaking opportunity for you. If you meet the above criteria and want to know more information, please email autumn@patientpower.info
tclementi
in
CLL America Support
7 years ago
OSU Venclexta + Imbruvica + Obinutuzumab Trial
Hey guys! Is anyone here currently enrolled in (or know someone who is) this triple therapy trial at the Ohio State Univ? I'm really interested in this, as it looks at both previously treated and untreated. Perhaps early intervention with several drugs will eradicate the clone and prevent selective pressures
Hey guys! Is anyone here currently enrolled in (or know someone who is) this triple therapy trial at the Ohio State Univ? I'm really interested in this, as it looks at both previously treated and untreated. Perhaps early intervention with several drugs will eradicate the clone and prevent selective pressures
JNDF2016
in
CLL Support
8 years ago
Dr Sharman's inaugural guest blog on Venclexta / Venetoclax / ABT-199, by Tom Boyd; Essential reading if you are considering this treatment
Considering treatment with Venclexta (or its myriad names) or Ibrurinib (and its myriad names) or ACP196/acalabrutinib (and I'm sure it will soon gain another name)? Then make certain that you first read this guest blog: http://www.cll-nhl.com/2016/04/venclexta.html Incidentally, I'd suggest that the
Considering treatment with Venclexta (or its myriad names) or Ibrurinib (and its myriad names) or ACP196/acalabrutinib (and I'm sure it will soon gain another name)? Then make certain that you first read this guest blog: http://www.cll-nhl.com/2016/04/venclexta.html Incidentally, I'd suggest that the
AussieNeil
Administrator
in
CLL Support
8 years ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
What Could a New Drug Approval Mean for CLL Patients?
Dr. William Wierda, medical director of the Department of Leukemia at the University of Texas MD Anderson Cancer Center, joins Patient Power to discuss the FDA approval of Venclexta (venetoclax) for use in CLL patients with the 17p deletion. Dr. Wierda reviews how the treatment works, its potential side
Dr. William Wierda, medical director of the Department of Leukemia at the University of Texas MD Anderson Cancer Center, joins Patient Power to discuss the FDA approval of Venclexta (venetoclax) for use in CLL patients with the 17p deletion. Dr. Wierda reviews how the treatment works, its potential side
mcints
in
CLL America Support
8 years ago
Breaking News: Expert Perspective on Venclexta (venetoclax) Approval
The U.S. Food and Drug Administration (FDA) has approved a new drug Venclexta (venetoclax) for use in CLL patients with the 17p deletion. Andrew Schorr interviewed CLL expert Dr. Thomas Kipps to get his perspective on what this new approval means for patients. http://www.patientpower.info/video/breaking-news-expert-perspective-on-venclexta-venetoclax-approval
The U.S. Food and Drug Administration (FDA) has approved a new drug Venclexta (venetoclax) for use in CLL patients with the 17p deletion. Andrew Schorr interviewed CLL expert Dr. Thomas Kipps to get his perspective on what this new approval means for patients. http://www.patientpower.info/video/breaking-news-expert-perspective-on-venclexta-venetoclax-approval
mcints
in
CLL America Support
8 years ago
Do you have 17 P Deletion? This is a must-read for you!
Breaking news! Venclexta (ABT-199) was just approved for CLL patients with 17 P deletion. Stay tuned for an expert interview for more information soon! In the meantime, learn more about the research that led to the drug approval here-http://www.patientpower.info/video/are-we-closer-to-a-cll-treatment-home-run
Breaking news! Venclexta (ABT-199) was just approved for CLL patients with 17 P deletion. Stay tuned for an expert interview for more information soon! In the meantime, learn more about the research that led to the drug approval here-http://www.patientpower.info/video/are-we-closer-to-a-cll-treatment-home-run
tclementi
in
CLL America Support
8 years ago
1
...
5
6
Filter results
Clear filters
Posted in
All communities
CLL Support
98 results
CLL America Support
6 results
Leukaemia CARE
2 results
Sort by
Most Relevant
Newest